Skip to main content
Premium Trial:

Request an Annual Quote

NCI’s Cancer Research Center Will Use BioFortis’ Labmatrix Software

NEW YORK, July 13 (GenomeWeb News) - BioFortis today said that the National Cancer Institute selected its Labmatrix software for use within the Center for Cancer Research.

 

CCR evaluated the software within the Neuro Oncology Branch.

 

Labmatrix is a web-based, enterprise translational research information-management software platform. It integrates clinical data with genomic, proteomic, and laboratory experimental data, and maintains annotated tissue banks.

 

The National Institutes of Health collaborated with BioFortis in developing Labmatrix.

 

CCR is composed of multiple labs, branches, and core facilities supporting both clinical and basic sciences, with a focus on translational cancer research.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.